14 September 2026
Review flags mixed NAION signal with GLP-1 drugs
Evidence on NAION with GLP-1 drugs is mixed, including a semaglutide odds ratio of 3.9 in 78 randomized trials.
The full briefing is in the app.
14 September 2026
Evidence on NAION with GLP-1 drugs is mixed, including a semaglutide odds ratio of 3.9 in 78 randomized trials.
The full briefing is in the app.